| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |